(Reuters) – Merck Co Inc reported better-than-expected quarterly earnings despite the negative impact of the stronger dollar, with solid sales growth from its vaccines and treatments for diabetes and HIV. The No. 2 U.S. drugmaker said on Friday it earned $1.79 billion, or 58 cents per share, in the second quarter. That …
Related posts:
#VIDEO | Israeli occupation forces shoot live ammo in Nabi Saleh – July 26, 2012
THE DISTILLERY: A try for NSW
Consumer confidence drops in Britain
Texting offers promise but also peril to campaigns
‘World will react to KSA-Bahrain merger’
Rich Weissensel: Software engineer creates monster truck using Delorean car from classic 1980s films